Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$6.15 - $7.76 $227 - $287
-37 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$13.75 - $23.86 $15,908 - $27,606
-1,157 Reduced 96.9%
37 $1,000
Q4 2020

Feb 16, 2021

BUY
$16.97 - $25.34 $19,634 - $29,318
1,157 Added 3127.03%
1,194 $1,000
Q2 2020

Aug 14, 2020

BUY
$22.0 - $60.7 $814 - $2,245
37 New
37 $1,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $57.2M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Cbiz Investment Advisory Services, LLC Portfolio

Follow Cbiz Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cbiz Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cbiz Investment Advisory Services, LLC with notifications on news.